Draupnir Bio Overview
- Founded
-
2017
- Status
-
Private
- Employees
-
21
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$33.2M
- Investors
-
7
Draupnir Bio General Information
Description
Provider of biopharmaceutical services intended to develop a new type of cholesterol-lowering medicine that prevents blood clots in the heart more effectively than the current medicine. The company's services offer an array of technology, protein chemistry, and advanced carbohydrate chemistry, enabling patients to have safe and effective glycomics-based therapy.
Contact Information
Website
www.draupnir.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Primary Office
- Ole Maaløes Vej 3
- 2200 Copenhagen
- Denmark
+45 51 00 00 00
Draupnir Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC (Series A) | 01-Oct-2019 | $33.2M | 000.00 | Completed | Pre-Clinical Trials | |
| 2. Grant | 30-Nov-2017 | 00.000 | Completed | Pre-Clinical Trials | ||
| 1. Accelerator/Incubator | 01-Jan-2017 | Completed | Pre-Clinical Trials |
Draupnir Bio Executive Team (7)
Draupnir Bio Board Members (6)
| Name | Representing | Role | Since |
|---|---|---|---|
| Emmanuelle Coutanceau Ph.D | Novo Holdings | Board Member | 000 0000 |
| Eva-Lotta Allan | Draupnir Bio | Chairman | 000 0000 |
| Robert Scott MD | Self | Board Member | 000 0000 |
| Roel Bulthuis | Inkef | Board Member | 000 0000 |
| Simon Glerup Ph.D | Draupnir Bio | Co-Founder, Chief Scientific Officer & Board Member | 000 0000 |
Draupnir Bio Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Draupnir Bio Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Gilde Healthcare Partners | Venture Capital | Minority | 000 0000 | 000000 0 | |
| High-Tech Gründerfonds | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Inkef | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Novo Holdings | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Novo Nordisk Fonden | Limited Partner | 000 0000 | 000000 0 |